Dr. Velamuri, M.D. is a board-certified Internal Medicine physician who has served on process improvement, health informatics, and patient safety committees at numerous large hospitals in and around the greater Houston area. He was named lead hospitalist at Baylor College of Medicine (BCM)- Catholic Health Initiatives (CHI) on the sepsis committee, appointed the 2018 Sepsis Champion for HCAHouston, and has served as the Medical Director of Kindred Hospitals Houston which is a Fortune 500 company. He is an active board member at the Texas Medical Center Sepsis Collaborative. He has worked as a hospitalist taking care of transplant patients for heart, lung, liver, and prosthetic hearts (LVADs) at CHI- St. Luke’s- Houston and as an attending physician at the Baylor College of Medicine prior to transitioning to HCA- Houston. He has been a guest speaker for GHSHRM ‘19 (Greater Houston Society for Healthcare Risk Management), the FBI’s Biotechnology Security Summit ‘19, HIMSS Houston educational session on sepsis workflow ’19, University of Berkley Cal Hacks for COVID panel 2020, and Keynote speaker for Stanford University’s Hack from Home healthcare innovation hackathon 2020. Dr. Velamuri is an appointed advisor to the TMC Innovation center companies– a partner with the US Department of Health and Human Services in their BARDA-led initiative to stop sepsis. He mentors and advises companies and healthcare systems internationally in the biotech space apart from serving on non-profit boards. He is driven to bring innovation to hospitals in order to decrease unnecessary suffering of patients as President and CEO of Luminare, Inc. His work with Luminare was awarded “Most Promising Web & IT Company” in the US by the Rice Alliance for Web & IT and is a part of the Texas Medical Center’s Innovation Institute (TMCx).